Publikationen Archiv - Seite 4 von 7

Benedikt Fritzsching, Marco Contoli, Celeste Porsbjerg, Sarah Buchs, Julie Rask Larsen, Lisa Elliott, Mercedes Romano Rogdriguez, Nick Freemantle. Long-term real-world effectiveness of allergy immunotherpay in patients with allergic rhinitis and asthma: Results from the REACT study, a retrospective cohort study. The Lancet Regional Health Volume 13, 100275, FEBRUARY 01, 2022, DOI:https://doi.org/10.1016/j.lanepe.2021.100275

Therapy areas: Immunology

Indications: Allergic Rhinitis, Asthma

March, S., Zimmermann, L., Kubat, D., Neumann, A., Schmitt, J. M., Baum, F., Schoffer, O., Arnold, K., Seifert, M., Kliemt, R., Häckl, D., Pfennig, A. & Swart, E. (2020). Methodische Herausforderungen bei der Nutzung von Daten von mehr als 70 gesetzlichen Krankenkassen – Ein Werkstattbericht aus der EVA64-Studie. Das Gesundheitswesen, 82(S 01), S. S4-S12. DOI:https://doi.org/10.1055/a-1036-6364 (abgerufen am 30.10.2023).

Therapy areas: Psychiatry

Indications: Mental disorders

Kathrin Kahnert, Marija Halbach, Mohammed Dagher, Axel Krinner, Elena Garal-Pantaler, Hana Mullerova, Michael Pollack. Initiation of single- and multiple-inhaler triple therapy for COPD and adoption of budesonide/glycopyrrolate/formoterol (BGF): pooled analysis from the AURA Germany study, European Respiratory Society (ERS) congress. 2024, September 07 - 11, Vienna. No DOI/URL available

Therapy areas: Respiratory

Indications: COPD

Horneff, G., Borchert, J., Heinrich, R., Kock, S., Klaus, P., Dally, H., Hagemann, C., Diesing, J. & Schönfelder, T. (2022). Incidence, prevalence, and comorbidities of juvenile idiopathic arthritis in Germany: a retrospective observational cohort health claims database study. Pediatric Rheumatology, 20(100), S. 1–13. DOI:https://doi.org/10.1186/s12969-022-00755-x (abgerufen am 27.10.2023).

Therapy areas: Immunology

Indications: Juvenile idiopathische arthritis

Birkeland, K. I., Bodegård, J., Banerjee, A., Kim, D. J., Norhammar, A., Eriksson, J. W., Thuresson, M., Okami, S., Ha, K. H., Kossack, N., Mamza, J. B., Zhang, R., Yajima, T., Komuro, I. & Kadowaki, T. (2021). Lower cardiorenal risk with sodium-glucose cotransporter-2 inhibitors versus dipeptidyl peptidase-4 inhibitors in patients with type 2 diabetes without cardiovascular and renal diseases: A large multinational observational study. Diabetes Obes Metab (Diabetes, Obesity and Metabolism), 23(1), S. 75–85. DOI:https://doi.org/10.1111/dom.14189 (abgerufen am 20.10.2023).

Therapy areas: Cardiovascular, Renal and Metabolism

Indications: Diabetes Type 2

Schrom, E., Alexander, T., Schulte, M., Garcia, T. B., Sewerin, P. & Borchert, J. (2023). Incidence, Prevalence and Management of Systemic Lupus Erythematosus in 4 Cohorts: a German Claims Data Analysis. EV.14. In: Deutsche Gesellschaft für Rheumatologie e. V. (Hrsg.). Deutscher Rheumatologiekongress 2023, 30.08–02.09.2023, Leipzig, S. 252. No DOI/URL available

Therapy areas: Immunology

Indications: Systemic Lupus Erythematosus

Alexander, T., Schulte, M., Borchert, J., Garcia, T. B. & Schrom, E. (2023). Incidence, Prevalence and Current Treatment Practice of Systemic Lupus Erythematosus: A German Claims Data Analysis. In: J. S. Smolen (Hrsg.). Abstracts. EULAR European Congress of Rheumatology. [Sonderheft]. EULAR 2023 31 May-3 June 2023. Annals of the Rheumatic Diseases, 82(Supplement 1), S. 1450. DOI:https://doi.org/10.1136/annrheumdis-2023-eular.478 (abgerufen am 06.11.2023).

Therapy areas: Immunology

Indications: Systemic Lupus Erythematosus

Birkeland KI, Bodegard J, Norhammar A, Kuiper JG, Georgiado E, Beekman-Hendriks WL, Thuresson M, Pignot M, Herings RMC, Kooy A. How representative of a general type 2 diabetes population are patients included in cardiovascular outcome trials with SGLT2 inhibitors? A large European observational study. Diabetes Obes Metab. 2019 Apr;21(4):968-974. doi: 10.1111/dom.13612.

Therapy areas: Cardiovascular, Renal and Metabolism

Indications: Diabetes Type 2

Parsekar K, Kossack N, Hernández I, Vogelmeier CF, Kolb N, Baak B, Swart-Polinder KMA, Simons S, Bengtsson C, Vojinovic-Dees D, Sin D, Hawkins N, McMullen S, Pham T, Corregidor García C, Martinez N, Sánchez-Covisa Hernández J, Abram M, Halbach M, van Burk L, Randhawa A, Nordon C. Healthcare Resource Utilization and Costs in Patients Experiencing Severe Cardiac Events Following a COPD Exacerbation: Results from the EXACOS-CV Studies in Spain, Germany , the Netherlands and Canada. Value in Health, Volume 26, Issue 11, S2 (December 2023). No DOI/URL available

Therapy areas: Respiratory

Indications: COPD

Kåre I Birkeland, Johan Bodegard, Jan W Eriksson, Anna Norhammar, Hermann Haller, Gerard C M Linssen, Amitava Banerjee, Marcus Thuresson, Suguru Okami, Elena Garal-Pantaler, Jetty Overbeek, Jil Billy Mamza, Ruiqi Zhang, Toshitaka Yajima, Issei Komuro, Takashi Kadowaki. Heart failure and chronic kidney disease manifestation and mortality risk associations in type 2 diabetes: A large multinational cohort study. Diabetes Obes Metab. 2020;22:1607–1618. DOI: 10.1111/dom.14074

Therapy areas: Cardiovascular, Renal and Metabolism

Indications: Diabetes Type 2

Feißel, A., Arnold, K., Häckl, D., Kliemt, R., Küster, D., Milarczyk, J., Neumann, A., Pfennig, A., Schmitt, J. M., Swart, E., Weiß, J. & March, S. (2016). Herausforderungen beim Datenhandling am Beispiel einer routinedatenbasierten und kassenübergreifenden Studie zur wissenschaftlichen Evaluation von Modellvorhaben nach §64b SGB V (EVA64). Das Gesundheitswesen, 78(08/09), S. A186. DOI:https://doi.org/10.1055/s-0036-1586695 (abgerufen am 25.10.2023).

Therapy areas: Psychiatry

Indications: Mental disorders

Armin Secker, Marc Pignot, Mohammed Dagher, Nils Kossack, Jason Schwartz, Ana Filipa Alexandre. Iatrogenic Ureteral Injury Rate in Abdominopelvic Surgeries in Germany: Feasibility Assessment Results. RCOG World Congress 2022, ASP5354 No DOI/URL available

Therapy areas: Urology

Indications: Urology, Surgery

Brestrich, G., Hagemann, C., Diesing, J., Kossack, N., Stark, J. H., Pilz, A., Angulo, F. J., Yu, H. & Suess, J. (2024). Incidence of Lyme Borreliosis in Germany: A retrospective observational healthcare claims study. Ticks and tick-borne diseases, 15(3), S. 102326. DOI:https://doi.org/10.1016/j.ttbdis.2024.102326.

Therapy areas: Infectious Diseases

Indications: Lyme Borreliosis

Müller, M., Wuppermann, A., Stahn, G. & Weinhold, I. (2023). Inanspruchnahme von pädiatrischen Präventivleistungen während der COVID-19-Pandemie: Evidenz basierend auf Routinedaten. [Vortrag]. 15. dggö Jahrestagung 2023. Deutsche Gesellschaft für Gesundheitsökonomie e.V., 14.03.2023, Hannover. 04.12.2023). No DOI/URL available

Therapy areas: General Health

Indications: General

Kraus MR, Kleine H, Thönnes S, Pignot M, Sanchez Gonzalez Y. Improvement of Hepatic and Extrahepatic Complications from Chronic Hepatitis C After Antiviral Treatment: A Retrospective Analysis of German Sickness Fund Data. Infect Dis Ther. 2018 Sep;7(3):339-352. doi: 10.1007/s40121-018-0205-2.

Therapy areas: Infectious Diseases

Indications: Hepatitis C

Vogelmeier, C. F., Friedrich, F. W., Timpel, P., Kossack, N., Diesing, J., Pignot, M., Abram, M. & Halbach, M. (2024). Impact of COPD on mortality: An 8-year observational retrospective healthcare claims database cohort study. Respiratory medicine, 222, S. 107506. DOI:https://doi.org/10.1016/j.rmed.2023.107506.

Therapy areas: Respiratory

Indications: COPD

Parsekar, K., Kossack, N., Hernández, I., Vogelmeier, C. F., Kolb, N., Baak, B. N., Swart-Polinder, K. M. A., Simons, S. O., Bengtsson, C., Vojinovic-Dees, D., Sin, D. D., Hawkins, N. M., McMullen, S., Pham, T., Corregidor García, C., Martinez, N., Sánchez-Covisa Hernández, J., Abram, M., Halbach, M., van Burk, L., Randhawa, A. & Nordon, C. (2023). Healthcare Resource Utilization and Costs in Patients Experiencing Severe Cardiac Events Following a COPD Exacerbation: Results from EXACOS-CV Studies in Spain, Germany, the Netherlands and Canada. [Vortrag]. ISPOR Europe 2023. ISPOR, 12.11.2023, Kopenhagen. Online: https://www.ispor.org/heor-resources/presentations-database/presentation/euro2023-3784/129353 (abgerufen am 03.01.2024).

Therapy areas: Respiratory

Indications: COPD

Bo Ding, Marc Pignot, Elena Garal-Pantaler, Beate Villinger, Barnabas Desta, Katharina Schmidt, Sarowar Golam, Heide Stirnadel-Farrant, Andreas Schwarting Clinical Characteristics, Health Care Resource Utilization, and Costs Associated With Flares in Patients With Systemic Lupus Erythematosus in Germany EULAR 2022 No DOI/URL available

Therapy areas: Immunology

Indications: Systemic Lupus Erythematosus

E.R. Hammond, H. Friedel, E. Garal-Pantaler, M. Pignot, E. Velthuis, X.Wang, H.Nab, B.Desta, A. Schwarting. Health Care Resource Utilisation (HCRU) and Cost Analyses of Systemic Lupus Erythematosus (SLE) as a Function of Disease Severity: Analysis of Real-World Claims Data from a German Sickness Fund. Ann. Rheum. Dis. 2018, DOI: 10.1136/annrheumdis-2018-eular.5150

Therapy areas: Immunology

Indications: Systemic Lupus Erythematosus

ER Hammond, H Friedel, E Garal-Pantaler, M Pignot, E Velthuis, X Wang, H Nab, B Desta, A Schwarting. Health Care Resource Use (HRU) and Medical Costs Analyses as a Function of Systemic Lupus Erythematosus (SLE) Disease Severity: Analysis of Claims Data of a German Sickness Fund. LUPUS 2018;5(Suppl 1):A1–A129, DOI: 10.1136/lupus-2018-abstract.204

Therapy areas: Immunology

Indications: Systemic Lupus Erythematosus

1 2 3 4 5 6 7

Publikationen

128